3726 - 3750 of 6171 Results
Title
Year
- Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates2020OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Best OA location URL: https://eprints.whiterose.ac.uk/159502/1/acschembio.9b01044.pdfCitation Count: 10
- Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease2020OPENTitle: Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s diseaseJournal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 49Issue #: 5Start Page: 786End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/ageing/afaa033Best OA location URL: https://academic.oup.com/ageing/article-pdf/49/5/786/33677028/afaa033.pdfCitation Count: 16
- Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide2020OPENTitle: Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 343End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12921Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/134126Citation Count: 260
- Contingent negative variation: a biomarker of abnormal attention in functional movement disorders2020OPENTitle: Contingent negative variation: a biomarker of abnormal attention in functional movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 6Start Page: 985End Page: 994Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/ene.14189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14189Citation Count: 17
- Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease2020OPENTitle: Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 5Start Page: 632End Page: 632Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2019.5154Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2761854/jamaneurology_ossenkoppele_2020_oi_190119.pdfCitation Count: 111
- Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease2020OPENTitle: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s diseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-020-0401-2Best OA location URL: https://www.nature.com/articles/s41597-020-0401-2.pdfCitation Count: 92
- Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease2020OPENTitle: Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 947End Page: 958Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8826749Citation Count: 81
-
OPENTitle: Diphasic Worsening of Freezing of Gait in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 325End Page: 328Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12918Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12918Citation Count: 11
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 30
-
OPENTitle: Validation of a Parkinson Disease Predictive Model in a Population-Based StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/2857608Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/2857608.pdfCitation Count: 9
-
OPENTitle: Well Water and Parkinson’s Disease in Medicare Beneficiaries: A Nationwide Case-Control StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 693End Page: 705Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191793Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7342021Citation Count: 11
- A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra2020OPENTitle: A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigraJournal Name: Aging CellPublisher: WileyVol: 19Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13115Citation Count: 60
- Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study2020OPENTitle: Disease progression and prognostic factors in multiple system atrophy: A prospective cohort studyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104813End Page: 104813Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104813Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0969996120300887?via%3DihubCitation Count: 66
-
OPENTitle: Tossing and Turning in Bed: Nocturnal Movements in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 959End Page: 968Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28006Citation Count: 48
- Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology2020OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 34
- Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study2020OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 59
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020OPENTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 79
-
OPENTitle: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 284End Page: 292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12915Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12915Citation Count: 16
-
OPENTitle: From Passive Patient to Engaged Partner: My Journey With Parkinson DiseaseJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 12Issue #: 2Start Page: e12566End Page: e12566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/12566Best OA location URL: https://jopm.jmir.org/2020/2/e12566/PDFCitation Count: 0
- Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism2020OPENTitle: Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 72Issue #:Start Page: 75End Page: 79Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.003Best OA location URL: http://hdl.handle.net/11577/3350481Citation Count: 20
- Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRI2020OPENTitle: Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRIJournal Name: PainPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 161Issue #: 6Start Page: 1255End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1097/j.pain.0000000000001829Best OA location URL: https://doi.org/10.1097/j.pain.0000000000001829Citation Count: 21
- LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis2020OPENTitle: LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.51071Best OA location URL: https://cdn.elifesciences.org/articles/51071/elife-51071-v2.pdfCitation Count: 102
- Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa2020OPENTitle: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of LevodopaJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/9716317Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/9716317.pdfCitation Count: 20
-
OPENTitle: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-59414-4Best OA location URL: https://www.nature.com/articles/s41598-020-59414-4.pdfCitation Count: 76
-
OPENTitle: Impulse control and related behaviors in Parkinson’s disease with dementiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 6Start Page: 944End Page: 950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.14169Best OA location URL: https://discovery.ucl.ac.uk/10093209/3/Schrag_Manuscript_EJN_revised_29-01-2020%5B1%5D.pdfCitation Count: 19